Recently, Tmaxtree biotechnology completed nearly 100 million yuan B round of financing. This round of financing is led by Qingkong SinoKing Capital, followed by Shanshui Green Energy. Three years ago, Qianhai Ark, a famous domestic investment institution, invested in Tmaxtree Biotechnology, which strongly promoted the company’s development. The financing will further accelerate the development and marketing of high-end scientific instruments in bio-medicine and biological manufacturing.
Tmaxtree Biotechnology is a well-known domestic life science instrument company that insists on original technology research and instrument innovation. It is a national high-tech enterprise and a provincial specialized and new enterprise. Incubated in the Wuxi Institute of Applied Technology of Tsinghua University, the initial team came from the biological breeding technology team of Tsinghua University; the company maintains long-term and in-depth strategic cooperation with scientific research teams of Tsinghua University, Chinese Academy of Sciences, Jiangnan University and other institutions.
Tmaxtree has built some core technology systems such as plasma biotechnology, microfluidics, automated detection technology and biosensor technology, and has developed more than 20 products such as Atmospheric Room Temperature Plasma mutagenesis breeding machine, Single-cell Micro-droplet Culture Omics System, Bioreaction Online Detection System, many of which are international firsts. After years of research and development, the company's products have achieved full coverage of cell culture and detection sorting systems across multiple levels, from picoliter, nanoliter, microliter to milliliters, and have creatively achieved the connection of different systems, giving full play to the advantages of systems at all levels; the relevant instruments and equipments are flexible in combination and have a wide range of applications, which can be widely used in many fields such as synthetic biology, bio-manufacturing, drug development, biological breeding, and biological detection, achieving an order of magnitude improvement in R&D efficiency.
With its outstanding technological innovation, the company has won "China Patent Excellence Award", "First Award of China Light Industry Federation" and "Gold Award of Geneva International Invention Exhibition". The products have obtained CE certification, UL certification, and are exported to Japan, United States, Denmark, Singapore, France, Russia and other countries.
The company is always customer-oriented, adhere to equipment innovation, method development and technical services, and strive to provide customers with "hardware equipment + method" complete sets of practical solutions. The team has developed dozens of biosensors for microfluidic systems, and has developed high-throughput cell culture and sorting methods to meet different user needs.
The development of the company is inseparable from the long-term tolerance, trust and support of our customers! Tmaxtree products have served more than 500 customers at home and abroad, and customers have published more than 2,000 papers using the products. The company will adhere to the pain points and actual needs of the industry as the guide, aiming to develop products that customers can "afford and use well", continuously optimize products, enhance the team's service capabilities, and contribute more to the development of the bio-industry.
Tmaxtree Biotechnology sincerely thanks the investment institutions for their support and trust! Scientific instruments are likened to the jewel in the crown of high-end manufacturing. The company will continue to uphold the corporate values of "down-to-earth, innovative, customer-oriented, and excellence" and work with peer companies to make more Chinese high-end scientific instruments go to the world.
Investment institution introduction:
SinoKing Capital (Qingkong (Tsinghua Holdings) SinoKing Capital Management (Beijing) Co., Ltd) was founded in 2013. Relying on the advantages of Tsinghua's industry, academia and research resources, adhering to the concept of "technology-based, finance-oriented", deeply cultivating strategic emerging industries and financial capital markets, it has become an important force in Tsinghua's industry to promote the coordinated development of industry and finance. It is a professional institution focusing on industrial investment and asset management among the member companies of Tsinghua Holding’s Asset Management Group. As of now, the total size of funds managed by SinoKing Capital exceeds RMB 25 billion.
Tianjin Venture Capital (Tianjin Venture Capital Management Co., LTD.) was established in 2003. Since its commercial operation, it has relied on its deep industry accumulation and government background, based in Tianjin and radiating across the country. It has been deeply involved in the venture capital field for 20 years, with a total fund size of 10 billion yuan, and has invested in more than 130 technology-based companies, with nearly 20% of its invested companies listed..
Shanshui Green Energy (Shanshui Green Energy Venture Capital Partnership (Limited Partnership) is a fund under Xingyuan Capital. Wuxi Xingyuan Private Equity Fund Management Co., Ltd. is a state-owned, mixed-ownership venture capital platform in Wuxi High-tech Zone, and is the vice-chairman unit of Wuxi High-tech Zone Venture Capital Promotion Association. Since its establishment, Xingyuan Capital has been deeply involved in the equity investment field, and has made enabling investments in multiple strategic emerging industries such as high-end manufacturing, bio-medicine, and new energy in the Yangtze River Delta region, covering the entire life cycle of technology companies. It has grown into a venture capital brand with a certain asset management scale and industry influence in the region.
Recently, Tmaxtree biotechnology completed nearly 100 million yuan B round of financing. This round of financing is led by Qingkong SinoKing Capital, followed by Shanshui Green Energy. Three years ago, Qianhai Ark, a famous domestic investment institution, invested in Tmaxtree Biotechnology, which strongly promoted the company’s development. The financing will further accelerate the development and marketing of high-end scientific instruments in bio-medicine and biological manufacturing.
Tmaxtree Biotechnology is a well-known domestic life science instrument company that insists on original technology research and instrument innovation. It is a national high-tech enterprise and a provincial specialized and new enterprise. Incubated in the Wuxi Institute of Applied Technology of Tsinghua University, the initial team came from the biological breeding technology team of Tsinghua University; the company maintains long-term and in-depth strategic cooperation with scientific research teams of Tsinghua University, Chinese Academy of Sciences, Jiangnan University and other institutions.
Tmaxtree has built some core technology systems such as plasma biotechnology, microfluidics, automated detection technology and biosensor technology, and has developed more than 20 products such as Atmospheric Room Temperature Plasma mutagenesis breeding machine, Single-cell Micro-droplet Culture Omics System, Bioreaction Online Detection System, many of which are international firsts. After years of research and development, the company's products have achieved full coverage of cell culture and detection sorting systems across multiple levels, from picoliter, nanoliter, microliter to milliliters, and have creatively achieved the connection of different systems, giving full play to the advantages of systems at all levels; the relevant instruments and equipments are flexible in combination and have a wide range of applications, which can be widely used in many fields such as synthetic biology, bio-manufacturing, drug development, biological breeding, and biological detection, achieving an order of magnitude improvement in R&D efficiency.
With its outstanding technological innovation, the company has won "China Patent Excellence Award", "First Award of China Light Industry Federation" and "Gold Award of Geneva International Invention Exhibition". The products have obtained CE certification, UL certification, and are exported to Japan, United States, Denmark, Singapore, France, Russia and other countries.
The company is always customer-oriented, adhere to equipment innovation, method development and technical services, and strive to provide customers with "hardware equipment + method" complete sets of practical solutions. The team has developed dozens of biosensors for microfluidic systems, and has developed high-throughput cell culture and sorting methods to meet different user needs.
The development of the company is inseparable from the long-term tolerance, trust and support of our customers! Tmaxtree products have served more than 500 customers at home and abroad, and customers have published more than 2,000 papers using the products. The company will adhere to the pain points and actual needs of the industry as the guide, aiming to develop products that customers can "afford and use well", continuously optimize products, enhance the team's service capabilities, and contribute more to the development of the bio-industry.
Tmaxtree Biotechnology sincerely thanks the investment institutions for their support and trust! Scientific instruments are likened to the jewel in the crown of high-end manufacturing. The company will continue to uphold the corporate values of "down-to-earth, innovative, customer-oriented, and excellence" and work with peer companies to make more Chinese high-end scientific instruments go to the world.
Investment institution introduction:
SinoKing Capital (Qingkong (Tsinghua Holdings) SinoKing Capital Management (Beijing) Co., Ltd) was founded in 2013. Relying on the advantages of Tsinghua's industry, academia and research resources, adhering to the concept of "technology-based, finance-oriented", deeply cultivating strategic emerging industries and financial capital markets, it has become an important force in Tsinghua's industry to promote the coordinated development of industry and finance. It is a professional institution focusing on industrial investment and asset management among the member companies of Tsinghua Holding’s Asset Management Group. As of now, the total size of funds managed by SinoKing Capital exceeds RMB 25 billion.
Tianjin Venture Capital (Tianjin Venture Capital Management Co., LTD.) was established in 2003. Since its commercial operation, it has relied on its deep industry accumulation and government background, based in Tianjin and radiating across the country. It has been deeply involved in the venture capital field for 20 years, with a total fund size of 10 billion yuan, and has invested in more than 130 technology-based companies, with nearly 20% of its invested companies listed..
Shanshui Green Energy (Shanshui Green Energy Venture Capital Partnership (Limited Partnership) is a fund under Xingyuan Capital. Wuxi Xingyuan Private Equity Fund Management Co., Ltd. is a state-owned, mixed-ownership venture capital platform in Wuxi High-tech Zone, and is the vice-chairman unit of Wuxi High-tech Zone Venture Capital Promotion Association. Since its establishment, Xingyuan Capital has been deeply involved in the equity investment field, and has made enabling investments in multiple strategic emerging industries such as high-end manufacturing, bio-medicine, and new energy in the Yangtze River Delta region, covering the entire life cycle of technology companies. It has grown into a venture capital brand with a certain asset management scale and industry influence in the region.
